American Society Of Hematology

SAN DIEGO — A higher ferritin threshold than that used by WHO and CDC is cost-effective for identifying and treating women with iron deficiency, according to study results presented at ASH Annual Meeting and Exposition.

SAN DIEGO — Increased fiber intake after allogeneic hematopoietic stem cell transplantation appeared linked to improved outcomes, according to study results presented at ASH Annual Meeting and Exposition.

Several hematologists will be honored during this year’s ASH Annual Meeting.

ASH will honor Judith Kleinerman, MD, with the 2024 ASH Exemplary Service Award during the ASH Annual Meeting.

Medical mistrust continues to be a major issue in the care of patients with multiple myeloma — particularly among Black individuals according to findings published in Cancer Medicine.

Mohandas Narla, DSc, may hold the title of American Society of Hematology president, but his focus for the next several months will extend far beyond this country’s borders.

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

Results of a phase 1 trial for chimeric antigen receptor T cells targeting an orphan receptor in patients with relapsed or refractory multiple myeloma “thrilled” researchers, based on data presented at ASH Annual Meeting and Exhibition.

SAN DIEGO — The volume of hematopoietic stem cell transplantation procedures for advanced diffuse large B-cell lymphoma has declined precipitously since 2019, study results presented at ASH Annual Meeting and Exhibition showed.

Curative potential at a longer follow-up, logistics and patient risk and eligibility are all important considerations when sequencing bispecific antibodies and chimeric antigen receptor T-cell therapy for advanced large B-cell lymphoma.